Loading EarQ.com

Hybrid Hearing Device May Expand Market for Implants

Maura Cosetti, MD, an LSU Health Shreveport otolaryngologist and head & neck surgery assistant professor, is currently offering a revolutionary hybrid hearing technology to those with hearing difficulties too pronounced for traditional hearing devices but not pronounced enough for a cochlear implant.

Recently approved by the U.S. Food and Drug Administration (FDA), the Cochlear Nucleus Hybrid Implant features traditional cochlear implant technology and a built-in hearing device to boost the wearer’s existing hearing range. By doing so, the roughly 738,000 Americans with severe-to-profound hearing loss will now have greater access to a more comfortable listening experience.

This hybrid approach is just one of the recent advancements made in implant technology, including an invisible implant and positive steps toward using gene therapy and biotechnology to bolster an implant’s strength.

Last updated: July 29, 2014

 

Related Information:

Information about cochlear implants
Invisible cochlear implant in the future?
Gene therapy and biotechnology come together to address hearing loss

 

Share this:
Relaxing

You may also be interested in:

 

Sign Up for Hearing Healthcare News
EarQ's monthly newsletter gives you helpful information on developments and fun facts about hearing healthcare and EarQ. We also include special offers, so be sure to keep an eye on your email inbox for the EarQ newsletter each month.

 

 

Welcome, customer!
Find nearest EarQ Provider
800.338.0705
SHOW MENU
Like EarQ on Facebook Follow EarQ on Twitter Follow EarQ on Pinterest Follow EarQ on LinkedIn
ZagThere are hundreds of EarQ providers nationwide. Find the one closest to you!